First orally active angiotensin-converting enzyme (ACE) inhibitor. IC50=2.14nM. Reversible and competitive inhibitor of LTA4 hydrolase (IC50=11μM). Inhibits angiogenesis. Antihypotensive agent.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|